Table 5.
Comparison of week 0 and week 8 in the experimental group.
| Areas | Peak pressure (kPa) | Maximum force (N) | Contact area (cm2) | ||||||
|---|---|---|---|---|---|---|---|---|---|
| 0PCAFO | 8PCAFO | P | 0PCAFO | 8PCAFO | P | 0PCAFO | 8PCAFO | P | |
| T1 | 105.7±27.8 | 141.1±34.9 | 0.022* | 131.0±62.6 | 171.4±57.0 | 0.123 | 11.5±2.6 | 11.5±1.0 | 0.964 |
| T2–T5 | 48.1±16.9 | 54.4±19.5 | 0.342 | 65.0±45.7 | 63.4±30.0 | 0.842 | 12.1±4.8 | 11.1±4.2 | 0.432 |
| M1 | 134.0±39.7 | 150.2±15.6 | 0.324 | 118.2±61.0 | 144.1±44.4 | 0.324 | 8.8±4.0 | 9.3±2.9 | 0.635 |
| M2 | 221.2±38.6 | 204.2±38.1 | 0.123 | 196.7±68.7 | 201.8±83.2 | 0.753 | 8.4±1.9 | 9.2±2.2 | 0.232 |
| M3 | 238.2±77.4 | 346.5±336.6 | 0.321 | 187.0±84.6 | 159.3±101.0 | 0.323 | 7.3±1.6 | 7.5±0.9 | 0.553 |
| M4 | 226.0±84.5 | 172.5±34.8 | 0.132 | 183.2±78.1 | 149.2±49.6 | 0.254 | 7.7±1.1 | 8.2±1.6 | 0.072 |
| M5 | 163.1±80.5 | 116.2±55.7 | 0.142 | 190.8±116.8 | 127.2±63.0 | 0.124 | 11.0±2.3 | 10.3±2.9 | 0.133 |
| MF | 111.1±26.7 | 99.7±18.6 | 0.123 | 390.4±150.0 | 360.0±148.5 | 0.253 | 33.1±8.3 | 34.5±12.5 | 0.523 |
| MH | 195.7±27.6 | 220.5±33.5 | 0.143 | 272.0±88.9 | 314.0±90.6 | 0.073 | 13.2±3.3 | 13.8±3.6 | 0.442 |
| LH | 196.2±36.7 | 212.4±32.4 | 0.121 | 234.7±76.6 | 269.1±96.8 | 0.082 | 11.5±3.1 | 12.1±2.9 | 0.343 |
*
P<0.05 is considered a significant difference; values are expressed as means ± standard deviation;
0CAFO – week 0 customized AFO; 8CAFO – week 8 customized AFO; T1 – hallux; T2–T5 – toes 2–5; M1 – first metatarsal; M2 – second metatarsal; M3 – third metatarsal; M4 – fourth metatarsal; M5 – fifth metatarsal; MF – midfoot; MH – medial heel; LH – lateral heel.